🇰🇷 Multihance in South Korea

Multihance (GADOBENATE DIMEGLUMINE) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Status: likely_approved

Multihance in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in South Korea

Frequently asked questions

Is Multihance approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for Multihance in South Korea?

Bracco is the originator. The local marketing authorisation holder may differ — check the official source linked above.